Effect of commercial nasal steroid preparation on bacterial growth.
Lisa Mary CherianClare CooksleyKatharina RichterMahnaz RamezanpourSathish ParamasivanPeter-John WormaldSarah VreugdeAlkis James PsaltisPublished in: International forum of allergy & rhinology (2019)
The commercial product Pulmicort has a direct antibacterial effect on the planktonic and biofilm forms of S aureus and MRSA. This effect is at least in part mediated through the excipient EDTA in the product. Excipients also influenced the antimicrobial activity of antibiotics depending on the bacterial strain and antibiotic tested.